Sajjad Ullah Mphil: The Impact of Pharmacist-Led Anticoagulation Care in VTE
Sajjad Ullah Mphil, Pharmacist at Shaukat Khanum Memorial Cancer Hospital and Research Centre, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I am happy to share that our article has been published, offering valuable insights into ‘Pharmacist-led anticoagulation care in cancer: Associations with bleeding and VTE recurrence.’
Cancer patients are at a significantly higher risk of both thrombosis and bleeding, making anticoagulation management particularly complex.
This study was conducted to explore the impact of pharmacist-led anticoagulation care, focusing on its role in optimizing therapy, minimizing bleeding risks, and reducing the recurrence of venous thromboembolism (VTE).
Our findings add to the growing evidence supporting the clinical value of pharmacist involvement in multidisciplinary cancer care.
This landmark reflects dedication, enthusiasm, and strong leadership support.
I would like to express my sincere gratitude to Sir Omar Akhlaq Bhutta and my supervisor, Dr. Inayat Ur Rehman, for their constant guidance and unwavering support throughout this journey.
I am also deeply thankful to my co-author Dr. Javeria Khalid for her persistent support during challenging times.
Special appreciation to Dr. Yasir Shah and Prof. Long Ming for their continuous encouragement, patience, and motivation toward progress.
This will contribute to improving patient care and advancing the role of pharmacists in clinical practice.”
Title: Pharmacist-led anticoagulation care in cancer: Associations with bleeding and VTE recurrence
Authors: Sajjad Ullah, Inayat Ur Rehman, Javeria Khalid, Yasar Shah, Omar Akhlaq Bhutta, Long Chiau Ming
Read the Full Article on Journal of Oncology Pharmacy Practice

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series